TSTanja Schmidt

Tanja Schmidt

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Tanja Schmidt has a total of 37 co-authors. Here are the top co-authors by number of shared publications:

  • Arnd Hoburg

    Sports Medicine & Arthroscopy Service, Department for Orthopaedic Surgery and Traumatology Charité – Universiätsmedizin Berlin

    1 shared publication
  • Axel Pruss

    University Tissue Bank, Institut of Transfusion Medicine Charité – Universitätsmedizin Berlin

    1 shared publication
  • Axel Pruss

    Institute of Transfusion Medicine, Charité-Universitätsmedizin Berlin, 10117 Berlin, Germany

    1 shared publication
  • Bella Donna

    Universitas Gadjah Mada

    1 shared publication
  • Britt Wildemann

    Experimental Trauma Surgery, Department of Trauma, Hand and Reconstructive Surgery, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany

    1 shared publication
  • Carsten Skurk

    Deutsches Herzzentrum der Charité, Department of Cardiology, Angiology and Intensive Care Medicine, Campus Benjamin Franklin , Berlin

    1 shared publication

Latest Publications

  • Open Access

    WHO Initiatives to Promote and Accelerate Research on Health Emergency and Disaster Risk Management (Health EDRM)

    by Ryoma Kayano, Virginia Murray, Tanja Schmidt, Donald A Donahue, Paul Barach, Jehan Al-Badri, Bella Donna, Tatsuhiko Kubo, Jussi Sane, Mike Clarke, et al.

    Background/Introduction: Disasters and emergencies cause devastating impacts on communities, infrastructure, economies, and health. Protecting health from emergencies and disasters are the goals in the WHO’s thirteenth and fourteenth General Program of Work (GPW 13 and GPW 14). Objectives: Build robust scientific evidence and support, facilitate, and celebrate reliable research to for informed decision-making and effective policy and practice. Method/Description: WHO established a global expert network in 2018, “WHO Thematic Platform for Health EDRM Research Network (Health EDRM RN)”. The WHO Centre for Health Development (WHO Kobe Centre (WKC)), the secretariat of the Health EDRM RN, facilitates international collaboration for better knowledge generation, synthesis, and dissemination. In 2021, in collaboration with 164 experts from WHO HQ, all Regional Offices, and 30 countries, WHO Guidance on Research Methods for Health EDRM (the Guidance) was developed, which provides concrete guidance on how to plan, conduct and report Health EDRM research. Results/Outcomes: The Health EDRM has promoted numerous training and policy meetings including (i) In 2023, a joint webinar by WHO Regional Office for Europe (EURO), WHO Regional Office for Eastern Mediterranean, and WKC;(ii) In 2024, a joint workshop for European countries and partners by WHO EURO and WKC with support of UK Health Security Agency; (iii) Symposiums and workshops in collaboration with academic societies including World Association of Disaster and Emergency Medicine, ASEAN Academic Conference, and Japanese Association for Disaster Medicine since 2021. Conclusion: WHO will continue to collate and improve scientific evidence that informs more effective and sustainable disaster and emergency policies and practices.


  • Open Access

    Preclinical assessment of a modified Occlutech left atrial appendage closure device in a porcine model

    by Markus Reinthaler, Johannes Grosshauser, Tanja Schmidt, Juliane Unger, Ross Morgan, Friederike Zimmermann, Johannes Hartung, Claudio Seppelt, Denitsa Meteva, Wolfram Haider, et al.

    Left atrial appendage (LAA) closure is being developed as an alternative for stroke prevention in patients with atrial fibrillation that cannot tolerate long-term oral anticoagulation. To assess the feasibility, safety, and performance of a novel modified Occlutech LAA closure device in a preclinical porcine model, the modified Occlutech modified Occlutech Plus LAA closure device was implanted in 12 female pigs (25–39 kg body weight) under fluoroscopic and transesophageal echocardiography (TEE) guidance. Procedural and technical success, as well as safety of LAA closure, were evaluated peri-procedurally and after 4, 8, and 12 weeks. Moreover, after 4, 8 and, 12 weeks animals were sacrificed for pathological analysis (e.g., thrombus formation, device ingrowth, endothelialization, and inflammation). All LAA closure devices were successfully implanted. On follow-up, no serious adverse events such as device-associated thrombus or translocalization/embolization were observed. A clinically non-significant pericarditis was observed in 4 animals at the time of autopsy. Endothelialization of the device was visible after 4 weeks, advanced after 8 weeks and completed after 12 weeks. Immunohistochemistry showed low amounts of inflammatory infiltration on the edges of the device. The results of this study indicate that implantation of a modified Occlutech LAA closure device is feasible with rapid endothelialization and low inflammatory infiltration in a porcine model. Human data are needed to further characterize safety and efficacy.


  • Open Access

    Comparative Analysis of Different Platelet Lysates and Platelet Rich Preparations to Stimulate Tendon Cell Biology: An In Vitro Study

    by Franka Klatte-Schulz, Tanja Schmidt, Melanie Uckert, Sven Scheffler, Ulrich Kalus, Markus Rojewski, Hubert Schrezenmeier, Axel Pruss, Britt Wildemann

    The poor healing potential of tendons is still a clinical problem, and the use of Platelet Rich Plasma (PRP) was hypothesized to stimulate healing. As the efficacy of PRPs remains unproven, platelet lysate (PL) could be an alternative with its main advantages of storage and characterization before use. Five different blood products were prepared from 16 male donors: human serum, two PRPs (Arthrex, (PRP-ACP); RegenLab (PRP-BCT)), platelet concentrate (apheresis, PC), and PL (freezing-thawing destruction of PC). Additionally, ten commercial allogenic PLs (AlloPL) from pooled donors were tested. The highest concentration of most growth factors was found in AlloPL, whereas the release of growth factors lasted longer in the other products. PRP-ACP, PRP-BCT, and PC significantly increased cell viability of human tenocyte-like cells, whereas PC and AlloPL increased Col1A1 expression and PRP-BCT increased Col3A1 expression. MMP-1, IL-1β, and HGF expression was significantly increased and Scleraxis expression decreased by most blood products. COX1 expression significantly decreased by PC and AlloPL. No clear positive effects on tendon cell biology could be shown, which might partially explain the weak outcome results in clinical practice. Pooled PL seemed to have the most beneficial effects and might be the future in using blood products for tendon tissue regeneration.


  • Sterilization with electron beam irradiation influences the biomechanical properties and the early remodeling of tendon allografts for reconstruction of the anterior cruciate ligament (ACL)

    by Tanja Schmidt, Arnd Hoburg, Christine Broziat, Mark D. Smith, Uwe Gohs, Axel Pruss, Sven Scheffler

    Although allografts for anterior cruciate ligament (ACL) replacement have shown advantages compared to autografts, their use is limited due to the risk of disease transmission and the limitations of available sterilization methods. Gamma sterilization has shown detrimental effects on graft properties at the high doses required for sufficient pathogen inactivation. In our previous in vitro study on human patellar tendon allografts, Electron beam (Ebeam) irradiation showed less detrimental effects compared to gamma sterilization (Hoburg et al. in Am J Sports Med 38(6):1134–1140, 2010). To investigate the biological healing and restoration of the mechanical properties of a 34 kGy Ebeam treated tendon allograft twenty-four sheep underwent ACL replacement with either a 34 kGy Ebeam treated allograft or a non-sterilized fresh frozen allograft. Biomechanical testing of stiffness, ultimate failure load and AP-laxity as well as histological analysis to investigate cell, vessel and myofibroblast-density were performed after 6 and 12 weeks. Native sheep ACL and hamstring tendons (HAT, each n = 9) served as controls. The results of a previous study analyzing the remodeling of fresh frozen allografts (n = 12) and autografts (Auto, n = 18) with the same study design were also included in the analysis. Statistics were performed using Mann–Whitney U test followed by Bonferroni-Holm correction. Results showed significantly decreased biomechanical properties during the early remodeling period in Ebeam treated grafts and this was accompanied with an increased remodeling activity. There was no recovery of biomechanical function from 6 to 12 weeks in this group in contrast to the results observed in fresh frozen allografts and autografts. Therefore, high dose Ebeam irradiation investigated in this paper cannot be recommended for soft tissue allograft sterilization.